|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Gamma Project - ACTU |
|---|---|
| Information provided by: | NIH AIDS Clinical Trials Information Service |
| ClinicalTrials.gov Identifier: | NCT00002182 |
Purpose
The purpose of this study is to see if megestrol acetate is safe and effective in treating HIV-infected children with failure to thrive (FTT).
| Condition | Intervention |
|---|---|
|
HIV Infections |
Drug: Megestrol acetate |
| Study Type: | Interventional |
| Study Design: | Treatment, Double-Blind, Efficacy Study |
| Official Title: | Megestrol Acetate For Failure To Thrive In Pediatric HIV |
Eligibility| Ages Eligible for Study: | 6 Months to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria
Patients must have:
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms are excluded:
Patients with any of the following prior conditions or symptoms are excluded:
Medical contraindications to megestrol acetate including a history of poorly-controlled hypertension, deep venous thrombosis, or heart failure.
History of prior megestrol acetate therapy in the past six months.
Contacts and Locations
More Information
| Study ID Numbers: | 266A, Gamma 005 |
| Study First Received: | November 2, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00002182 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
Placebos Appetite Stimulants Megestrol Acetate Failure to Thrive |
|
Sexually Transmitted Diseases, Viral Slow Virus Diseases Contraceptive Agents Antineoplastic Agents Contraceptives, Oral Physiological Effects of Drugs Contraceptive Agents, Female Reproductive Control Agents Infection Pathologic Processes Failure to Thrive Therapeutic Uses Contraceptives, Oral, Synthetic Retroviridae Infections Appetite Stimulants |
RNA Virus Infections Immune System Diseases Antineoplastic Agents, Hormonal Acquired Immunodeficiency Syndrome Central Nervous System Stimulants Megestrol Immunologic Deficiency Syndromes Pharmacologic Actions Virus Diseases HIV Infections Sexually Transmitted Diseases Growth Disorders Lentivirus Infections Central Nervous System Agents Megestrol Acetate |